Follow
NGS
NGS: (Next-generation sequencing) also known as high-throughput sequencing, is the catch-all term used to illustrate a number of different modern sequencing technologies including: Illumina (Solexa) sequencing. Roche 454 sequencing. Ion torrent: Proton / PGM sequencing.
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
SEP 27, 2023 | 9:00 AM
Join our webinar where we will highlight key NextSeq™ 1000 and 2000 product updates and features of the on-board DRAGEN Bio-IT platform. We will cover the basics of how the flexibility...
SEP 14, 2023 | 8:30 PM
Wastewater-based surveillance is valuable as it allows for the detection of pathogens before symptomatic cases are identified. In Korea, wastewater surveillance has been implemented, and the...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
SEP 07, 2023 | 8:00 AM
Advancements in Next Generation Sequencing (NGS) are changing the genomics industry, favoring those with scale. Quest Diagnostics' clinical expertise, combined with our infrastructure, p...
JUL 25, 2023 | 8:00 PM
NEED ABSTRACT Learning Objectives Understand how the challenges of amplification from low input DNA, including single cells, can be overcome Discover why more researchers are using a next ge...
JUL 11, 2023 | 7:00 AM
Feeding the world in the midst of climate change and an ever-growing population demands scientists have access to scalable, flexible and sustainable genomic tools that add value to animal br...
JUN 15, 2023 | 7:00 AM
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
JUN 13, 2023 | 2:00 PM
Prompt and early diagnosis of sexually transmitted infections (STIs) is important to enable appropriate treatment and help prevent further transmission. Clinical testing labs require STI tes...
MAY 31, 2023 | 6:00 AM
Although metagenomic next-generation sequencing (mNGS) is increasingly used in clinical microbiological diagnosis, especially for rare or complicated infectious diseases, the applications of...
MAY 24, 2023 | 8:00 AM
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...
MAY 16, 2023 | 12:00 PM
Learning Objectives: 1. Describe alternative (non-B) DNA structures, how prevalent are they and what are their biological implications? 2. Explain why non-B DNA structures might be relevant...
MAY 16, 2023 | 5:30 AM
Genomic testing based on chromosome microarray (CMA) and Next Generation Sequencing (NGS) revolutionized clinical genetics. That said, microarray, targeted panel, exome and generic whole gen...
MAR 30, 2023 | 12:05 PM
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...